Amplifica Expands Pipeline for Hair Loss

Exclusive Licensing Agreement Allows for Access to Promising Early-Stage Protein SAN DIEGO, Jan. 26, 2023 /PRNewswire/ — Amplifica Holdings Group, Inc. (“Amplifica”), a privately held, clinical-stage biopharmaceutical company announced the signing of an exclusive license agreement with…

Click here to view original post

ADVERTISEMENT — Advertise With Biotech Networks